Related content

In vivo anti-melanoma efficacy of allo-restricted CTLs specific for melanoma expanded by artificial antigen-presenting cells

By Lu Xiao-ling  

Cancer Immunology, Immunotherapy, Vol. 58, Iss. 4, 2009-04 ,pp. : 629-638

Springer Publishing Company

Access to resources Recommend Favorite

In vivo functional efficacy of tumor-specific T cells expanded using HLA-Ig based artificial antigen presenting cells (aAPC)

By Durai Malarvizhi  

Cancer Immunology, Immunotherapy, Vol. 58, Iss. 2, 2009-02 ,pp. : 209-220

Springer Publishing Company

Access to resources Recommend Favorite

Antigen-presenting cells containing multiple costimulatory molecules promote activation and expansion of human antigen-specific memory CD8 + T cells

By Yang Sixun  

Cancer Immunology, Immunotherapy, Vol. 58, Iss. 4, 2009-04 ,pp. : 503-515

Springer Publishing Company

Access to resources Recommend Favorite

Anti-chondroitin sulfate proteoglycan 4-specific antibodies modify the effects of vemurafenib on melanoma cells differentially in normoxia and hypoxia

By                

International Journal of Oncology, Vol. 47, Iss. 1, 2015-01 ,pp. : 81-90

Spandidos Publications

Access to resources Recommend Favorite

Immune stimulatory antigen loaded particles combined with depletion of regulatory T-cells induce potent tumor specific immunity in a mouse model of melanoma

By Goforth Robin  

Cancer Immunology, Immunotherapy, Vol. 58, Iss. 4, 2009-04 ,pp. : 517-530

Springer Publishing Company

Access to resources Recommend Favorite